fluorobenzenes has been researched along with Intracranial Arteriosclerosis in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Liu, B; Wang, FJ; Wang, YN; Zhang, JY; Zhang, WN | 1 |
1 other study(ies) available for fluorobenzenes and Intracranial Arteriosclerosis
| Article | Year |
|---|---|
Effect of rosuvastatin on OX40L and PPAR-γ expression in human umbilical vein endothelial cells and atherosclerotic cerebral infarction patients.
Topics: Case-Control Studies; Cerebral Infarction; Female; Fluorobenzenes; Human Umbilical Vein Endothelial Cells; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Intracranial Arteriosclerosis; Male; OX40 Ligand; PPAR gamma; Pyrimidines; Rosuvastatin Calcium; Sulfonamides | 2014 |